Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

173 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma.
Cheng Z, Mirza H, Ennis DP, Smith P, Morrill Gavarró L, Sokota C, Giannone G, Goranova T, Bradley T, Piskorz A, Lockley M; BriTROC-1 Investigators; Kaur B, Singh N, Tookman LA, Krell J, McDermott J, Macintyre G, Markowetz F, Brenton JD, McNeish IA. Cheng Z, et al. Among authors: krell j. Clin Cancer Res. 2022 Jul 1;28(13):2911-2922. doi: 10.1158/1078-0432.CCR-21-1643. Clin Cancer Res. 2022. PMID: 35398881 Free PMC article.
Serum miR-1290 as a marker of pancreatic cancer--letter.
Frampton AE, Krell J, Kazemier G, Giovannetti E. Frampton AE, et al. Among authors: krell j. Clin Cancer Res. 2013 Sep 15;19(18):5250-1. doi: 10.1158/1078-0432.CCR-13-1620. Epub 2013 Jul 25. Clin Cancer Res. 2013. PMID: 23888071 No abstract available.
Safe administration of chemotherapy in mast cell activation syndrome.
Lythgoe MP, Krell J, McNeish IA, Tookman L. Lythgoe MP, et al. Among authors: krell j. J Oncol Pharm Pract. 2021 Jun;27(4):1005-1010. doi: 10.1177/1078155220953879. Epub 2020 Oct 9. J Oncol Pharm Pract. 2021. PMID: 33032491 Free PMC article.
The application of metabolomics in ovarian cancer management: a systematic review.
Ahmed-Salim Y, Galazis N, Bracewell-Milnes T, Phelps DL, Jones BP, Chan M, Munoz-Gonzales MD, Matsuzono T, Smith JR, Yazbek J, Krell J, Ghaem-Maghami S, Saso S. Ahmed-Salim Y, et al. Among authors: krell j. Int J Gynecol Cancer. 2021 May;31(5):754-774. doi: 10.1136/ijgc-2020-001862. Epub 2020 Oct 26. Int J Gynecol Cancer. 2021. PMID: 33106272
Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial.
Morgan RD, McNeish IA, Cook AD, James EC, Lord R, Dark G, Glasspool RM, Krell J, Parkinson C, Poole CJ, Hall M, Gallardo-Rincón D, Lockley M, Essapen S, Summers J, Anand A, Zachariah A, Williams S, Jones R, Scatchard K, Walther A, Kim JW, Sundar S, Jayson GC, Ledermann JA, Clamp AR. Morgan RD, et al. Among authors: krell j. Lancet Oncol. 2021 Feb;22(2):277-288. doi: 10.1016/S1470-2045(20)30591-X. Epub 2020 Dec 22. Lancet Oncol. 2021. PMID: 33357510 Clinical Trial.
Efficacy and Safety of Weekly Paclitaxel Plus Vistusertib vs Paclitaxel Alone in Patients With Platinum-Resistant Ovarian High-Grade Serous Carcinoma: The OCTOPUS Multicenter, Phase 2, Randomized Clinical Trial.
Banerjee S, Giannone G, Clamp AR, Ennis DP, Glasspool RM, Herbertson R, Krell J, Riisnaes R, Mirza HB, Cheng Z, McDermott J, Green C, Kristeleit RS, George A, Gourley C, Lewsley LA, Rai D, Banerji U, Hinsley S, McNeish IA. Banerjee S, et al. Among authors: krell j. JAMA Oncol. 2023 May 1;9(5):675-682. doi: 10.1001/jamaoncol.2022.7966. JAMA Oncol. 2023. PMID: 36928279 Free PMC article. Clinical Trial.
173 results